Contact this trialFirst, we need to learn more about you.
CDK4/6 Inhibitor
Abemaciclib + Temozolomide for Brain Tumors
Recruiting1 awardPhase 2
Phoenix, Arizona
This trial aims to see if adding abemaciclib to the chemotherapy drug temozolomide is helpful for treating a specific type of brain tumor. If you join the trial, your participation could
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.